Fabien Guillemot and Bruno Brisson of Poietis biotechnology lab call their model of human skin "Poieskin" , which they produce via 3D bioprinting. The French startup near Bordeaux had been carrying out experiments to create a structure with dermal and epidermal components since 2014. The model was presented in Washington, USA, at a conference on additive manufacturing in healthcare. The first partners include the cosmetics companies L’Oréal and BASF Beauty Care Solutions.
Scientists at the Queen Mary University in London also developed a 3D printing method that combines natural-tissue molecules with 3D printing to reverse-engineer organs. Researchers at Universidad Carlos III de Madrid have even built a 3D bioprinter that makes skin from human plasma. The bio ink consists of blood plasma, fibroblasts and keratinocytes, i.e. callus-forming cells. These ingredient are taken from the patients themselves, who are often burn victims. Many lives have already been saved using skin made in the laboratory.